ampicillin has been researched along with daptomycin in 34 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (14.71) | 18.7374 |
| 1990's | 6 (17.65) | 18.2507 |
| 2000's | 4 (11.76) | 29.6817 |
| 2010's | 15 (44.12) | 24.3611 |
| 2020's | 4 (11.76) | 2.80 |
| Authors | Studies |
|---|---|
| Eliopoulos, GM; Moellering, RC; Thauvin-Eliopoulos, C | 1 |
| Bayer, AS; Eliopoulos, GM; Grayson, ML; Ramos, MC | 1 |
| Bingen, E; Doit, C; Lambert-Zechovsky, N; Leclercq, R; Mariani-Kurkdjian, P | 1 |
| Fasching, CE; Gerding, DN; Moody, JA; Peterson, LR; Sinn, LM | 1 |
| Fontana, R; Grossato, A; Ligozzi, M; Tonin, EA | 1 |
| Cordin, X; Duez, JM; Kazmierczak, A; Péchinot, A; Siébor, E | 1 |
| Liu, C; Ratner, HB; Stratton, CW; Weeks, LS | 1 |
| Canawati, HN; Ginunas, VJ; Montgomerie, JZ; Sapico, FL | 1 |
| Verbist, L | 1 |
| Gilligan, PH; Hodinka, RL; Jack-Wait, K; Walden, TP; Wannamaker, N | 1 |
| Landman, D; Mobarakai, N; Quale, JM | 1 |
| Houck, H; Rand, KH | 1 |
| Lehn, N; Naber, KG; Wagenlehner, FM; Witte, W | 1 |
| Federspiel, JJ; Fowler, VG; Kanafani, ZA | 1 |
| Arias, CA; Moore, J; Murray, BE; Panesso, D; Singh, KV; Torres, HA; Wanger, A | 1 |
| Entenza, JM; Giddey, M; Moreillon, P; Vouillamoz, J | 1 |
| Bayer, AS; Mishra, NN; Moise, PA; Nizet, V; Pogliano, J; Sakoulas, G; Tsuji, BT; Yang, SJ; Yeaman, MR | 1 |
| Goodwin, M; Iznaola, O; Mohr, J; Sierra-Hoffman, M | 1 |
| Bétrisey, B; Furustrand Tafin, U; Jeddari, S; Maiolo, EM; Oliva, A; Trampuz, A | 1 |
| Ferreira, TP; Gobbi, DD; Hofer, E; Matté, GR; Matté, MH; Moreno, AM; Moreno, LZ; Paixão, R; Raimundo, DC; Reis, CM | 1 |
| Barber, KE; Hall Snyder, A; Rybak, MJ; Sakoulas, G; Werth, BJ | 1 |
| Arias, CA; Carvajal, LP; Diaz, L; Miller, WR; Munita, JM; Murray, BE; Panesso, D; Reyes, J; Rincon, S; Rojas, NL; Shamoo, Y; Tran, TT; Weinstock, GM; Wollam, A | 1 |
| Barber, KE; Nonejuie, P; Pogliano, J; Rybak, MJ; Sakoulas, G; Tran, KN; Werth, BJ | 1 |
| Barber, KE; Raut, A; Rybak, MJ; Smith, JR | 1 |
| Carvalho, M; Charlton, CL; Hindler, JA; Humphries, R; Kelesidis, T; Miller, SA; Nizet, V; Nonejuie, P; Pogliano, J; Sakoulas, G; Wong-Beringer, A | 1 |
| Burgmann, H; Kussmann, M; Pichler, P; Poeppl, W; Reznicek, G; Schuster, L; Wiesholzer, M; Zeitlinger, M | 1 |
| Henson, KE; Rybak, MJ; Sakoulas, G; Smith, JR; Yim, J | 1 |
| Almela, M; Armero, Y; Brunet, M; Casals, G; Falces, C; Fuster, D; García-de-la-Mària, C; García-González, J; Llopis, J; Marco, F; Miró, JM; Moreno, A; Ninot, S; Pericàs, JM; Quintana, E | 1 |
| Hayashi, R; Higashi, Y; Kawago, K; Matsumoto, K; Nakamura, S; Ogami, C; Sakamaki, I; Tokui, K; Tsuji, Y; Yamamoto, Y | 1 |
| Do, C; Fierer, J; King, H; Kumaraswamy, M; Nizet, V; Nonejuie, P; Pogliano, J; Sakoulas, G; Tseng, GW | 1 |
| Arias, CA; Dinh, AQ; Kebriaei, R; Khan, A; Murray, BE; Rice, SA; Rybak, MJ; Singh, KV; Stamper, KC; Tran, TT | 1 |
| Futamura, Y; Matsuyama, K; Sugiyama, K; Watanuki, H | 1 |
| Russo, A; Venditti, M | 1 |
| Chen, J; Chen, Z; Deng, Q; Qu, D; Tang, Y; Wu, Y; Xiong, Y; Yu, Z; Zhao, Y; Zheng, J | 1 |
1 review(s) available for ampicillin and daptomycin
| Article | Year |
|---|---|
Listeria monocytogenes endocarditis: case report, review of the literature, and laboratory evaluation of potential novel antibiotic synergies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Ceftriaxone; Child; Child, Preschool; Daptomycin; Drug Synergism; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Humans; Listeria monocytogenes; Listeriosis; Male; Microbial Sensitivity Tests; Middle Aged; Young Adult | 2018 |
33 other study(ies) available for ampicillin and daptomycin
| Article | Year |
|---|---|
Contribution of animal models in the search for effective therapy for endocarditis due to enterococci with high-level resistance to gentamicin.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Daptomycin; Disease Models, Animal; Drug Resistance, Microbial; Endocarditis, Bacterial; Enterococcus faecalis; Gentamicins; Glycopeptides; Gram-Positive Bacterial Infections; Peptides; Rats; Teicoplanin; Vancomycin | 1992 |
Comparison of daptomycin, vancomycin, and ampicillin-gentamicin for treatment of experimental endocarditis caused by penicillin-resistant enterococci.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Daptomycin; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus; Enterococcus faecalis; Female; Gentamicins; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Penicillin Resistance; Peptides; Rabbits; Vancomycin | 1992 |
Bactericidal activity of vancomycin, daptomycin, ampicillin and aminoglycosides against vancomycin-resistant Enterococcus faecium.
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Conjugation, Genetic; Daptomycin; Drug Resistance, Microbial; Drug Synergism; Kinetics; Microbial Sensitivity Tests; Peptides; Streptococcal Infections; Streptococcus; Vancomycin | 1990 |
Treatment evaluation of experimental staphylococcal infections: comparison of beta-lactam, lipopeptide, and glycopeptide antimicrobial therapy.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Cefamandole; Cefoperazone; Cephalothin; Daptomycin; Disease Models, Animal; Female; Glycopeptides; Oxacillin; Peptides; Rabbits; Staphylococcal Infections; Sulbactam; Teicoplanin; Vancomycin | 1990 |
In vitro response to bactericidal activity of cell wall-active antibiotics does not support the general opinion that enterococci are naturally tolerant to these antibiotics.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteria; Cell Wall; Daptomycin; Drug Resistance, Microbial; Enterococcus faecalis; Microbial Sensitivity Tests; Penicillins; Peptides; Piperacillin; Vancomycin | 1990 |
[Bactericidal activity of daptomycin and vancomycin alone or in combination with tobramycin, netilmicin or ampicillin against enterococcus].
Topics: Ampicillin; Anti-Bacterial Agents; Daptomycin; Drug Therapy, Combination; Enterococcus faecalis; Microbial Sensitivity Tests; Netilmicin; Peptides; Streptococcus; Tobramycin; Vancomycin | 1989 |
Bactericidal activity of deptomycin (LY146032) compared with those of ciprofloxacin, vancomycin, and ampicillin against enterococci as determined by kill-kinetic studies.
Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Daptomycin; Enterococcus faecalis; Humans; Microbial Sensitivity Tests; Peptides; Vancomycin | 1987 |
LY146032, alone and in combination with gentamicin, for the treatment of enterococcal pyelonephritis in the rat model.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Daptomycin; Disease Models, Animal; Drug Therapy, Combination; Enterococcus faecalis; Gentamicins; Male; Microbial Sensitivity Tests; Peptides; Pyelonephritis; Random Allocation; Rats; Rats, Inbred Strains; Streptococcal Infections; Vancomycin | 1988 |
In vitro activity of LY146032, a new lipopeptide antibiotic, against gram-positive cocci.
Topics: Ampicillin; Anti-Bacterial Agents; Daptomycin; Kinetics; Microbial Sensitivity Tests; Oxacillin; Staphylococcus; Streptococcus; Vancomycin | 1987 |
Comparative in vitro activity of LY146032 (daptomycin), a new lipopeptide antimicrobial.
Topics: Ampicillin; Anti-Bacterial Agents; Clostridium; Daptomycin; Glycopeptides; Gram-Positive Bacteria; Humans; Listeria monocytogenes; Microbial Sensitivity Tests; Oxacillin; Peptides; Staphylococcus; Streptococcus; Teicoplanin; Vancomycin | 1987 |
Bactericidal activities of peptide antibiotics against multidrug-resistant Enterococcus faecium.
Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Daptomycin; Depsipeptides; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus faecalis; Humans; Microbial Sensitivity Tests; Peptides, Cyclic; Vancomycin | 1994 |
Daptomycin synergy with rifampicin and ampicillin against vancomycin-resistant enterococci.
Topics: Ampicillin; Anti-Bacterial Agents; Culture Media; Daptomycin; Drug Synergism; Enterococcus; Microbial Sensitivity Tests; Penicillins; Rifampin; Vancomycin Resistance | 2004 |
In vitro activity of daptomycin versus linezolid and vancomycin against gram-positive uropathogens and ampicillin against enterococci, causing complicated urinary tract infections.
Topics: Acetamides; Ampicillin; Anti-Bacterial Agents; Cross Infection; Daptomycin; Enterococcus; Genotype; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcus; Urinary Tract Infections; Vancomycin | 2005 |
Infective endocarditis caused by daptomycin-resistant Enterococcus faecalis: a case report.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteremia; Catheters, Indwelling; Daptomycin; Drug Resistance, Bacterial; Endocarditis, Bacterial; Enterococcus faecalis; Female; Gentamicins; Humans; Middle Aged | 2007 |
Failure of daptomycin monotherapy for endocarditis caused by an Enterococcus faecium strain with vancomycin-resistant and vancomycin-susceptible subpopulations and evidence of in vivo loss of the vanA gene cluster.
Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Daptomycin; DNA, Bacterial; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecium; Gentamicins; Gram-Positive Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multigene Family; Treatment Failure; Vancomycin Resistance | 2007 |
In vitro prevention of the emergence of daptomycin resistance in Staphylococcus aureus and enterococci following combination with amoxicillin/clavulanic acid or ampicillin.
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Mutation; Selection, Genetic; Staphylococcus aureus | 2010 |
Ampicillin enhances daptomycin- and cationic host defense peptide-mediated killing of ampicillin- and vancomycin-resistant Enterococcus faecium.
Topics: Ampicillin; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Bacteremia; beta-Lactams; Daptomycin; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecium; Humans; Microbial Sensitivity Tests; Models, Biological; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2012 |
Combination therapy with ampicillin and daptomycin for treatment of Enterococcus faecalis endocarditis.
Topics: Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Daptomycin; Drug Synergism; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests | 2012 |
Activities of fosfomycin and rifampin on planktonic and adherent Enterococcus faecalis strains in an experimental foreign-body infection model.
Topics: Acetamides; Ampicillin; Animals; Anti-Bacterial Agents; Bacterial Adhesion; Biofilms; Calorimetry; Daptomycin; Disease Models, Animal; Drug Therapy, Combination; Enterococcus faecalis; Foreign Bodies; Fosfomycin; Gentamicins; Gram-Positive Bacterial Infections; Guinea Pigs; Linezolid; Male; Microbial Sensitivity Tests; Oxazolidinones; Rifampin; Vancomycin | 2014 |
Characterization of antibiotic resistance in Listeria spp. isolated from slaughterhouse environments, pork and human infections.
Topics: Abattoirs; Ampicillin; Animals; Anti-Bacterial Agents; Carbapenems; Clindamycin; Daptomycin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Erythromycin; Fluoroquinolones; Genes, Bacterial; Humans; Listeria; Microbial Sensitivity Tests; Oxacillin; Swine; Tetracycline | 2014 |
Evaluation of the novel combination of daptomycin plus ceftriaxone against vancomycin-resistant enterococci in an in vitro pharmacokinetic/pharmacodynamic simulated endocardial vegetation model.
Topics: Ampicillin; Anti-Bacterial Agents; Ceftriaxone; Daptomycin; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2014 |
Whole-genome analyses of Enterococcus faecium isolates with diverse daptomycin MICs.
Topics: Amino Acid Substitution; Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; Boron Compounds; Cell Membrane; Cell Wall; Daptomycin; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Fluorescent Dyes; Gene Expression; Genes, Regulator; Genome, Bacterial; Microbial Sensitivity Tests; Vancomycin; Vancomycin Resistance | 2014 |
Ceftobiprole and ampicillin increase daptomycin susceptibility of daptomycin-susceptible and -resistant VRE.
Topics: Ampicillin; Cephalosporins; Daptomycin; Dose-Response Relationship, Drug; Drug Synergism; Enterococcus; Humans; Microbial Sensitivity Tests; Vancomycin Resistance | 2015 |
β-Lactams enhance daptomycin activity against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium in in vitro pharmacokinetic/pharmacodynamic models.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactams; Ceftaroline; Cephalosporins; Daptomycin; Enterococcus faecalis; Enterococcus faecium; Ertapenem; Microbial Sensitivity Tests; Vancomycin; Vancomycin-Resistant Enterococci | 2015 |
In vitro activity of daptomycin in combination with β-lactams, gentamicin, rifampin, and tigecycline against daptomycin-nonsusceptible enterococci.
Topics: Ampicillin; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; beta-Lactams; Cathelicidins; Daptomycin; DNA Mutational Analysis; DNA, Bacterial; Drug Combinations; Drug Interactions; Drug Resistance, Bacterial; Drug Synergism; Enterococcus; Enterococcus faecium; Ertapenem; Gentamicins; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Mutation; Rifampin; Vancomycin Resistance | 2015 |
The influence of different peritoneal dialysis fluids on the in vitro activity of ampicillin, daptomycin, and linezolid against Enterococcus faecalis.
Topics: Ampicillin; Anti-Bacterial Agents; Daptomycin; Dialysis Solutions; Enterococcus faecalis; Humans; Linezolid; Microbial Sensitivity Tests; Microbial Viability; Peritoneal Dialysis; Time Factors | 2015 |
β-Lactamase Inhibitors Enhance the Synergy between β-Lactam Antibiotics and Daptomycin against Methicillin-Resistant Staphylococcus aureus.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Daptomycin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Sulbactam; Tazobactam | 2017 |
Early in vitro development of daptomycin non-susceptibility in high-level aminoglycoside-resistant Enterococcus faecalis predicts the efficacy of the combination of high-dose daptomycin plus ampicillin in an in vivo model of experimental endocarditis.
Topics: Aminoglycosides; Ampicillin; Animals; Anti-Bacterial Agents; Ceftriaxone; Daptomycin; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Rabbits | 2017 |
Daptomycin-induced Eosinophilic Pneumonia and a Review of the Published Literature.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bronchoalveolar Lavage Fluid; Daptomycin; Eosinophils; Humans; Leukocyte Count; Male; Middle Aged; Pulmonary Eosinophilia; Sulbactam | 2018 |
Mechanistic Insights Into the Differential Efficacy of Daptomycin Plus β-Lactam Combinations Against Daptomycin-Resistant Enterococcus faecium.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; beta-Lactams; Ceftaroline; Cephalosporins; Daptomycin; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecium; Ertapenem; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Rats; Sequence Alignment; Transcriptome | 2020 |
Prosthetic valve endocarditis caused by silent infection of methicillin-resistant coagulase-negative staphylococci.
Topics: Aged; Ampicillin; Anti-Bacterial Agents; Blood Culture; Daptomycin; Debridement; Echocardiography; Endocarditis, Bacterial; Female; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Humans; Intracranial Embolism; Magnetic Resonance Imaging; Methicillin Resistance; Mitral Valve Stenosis; Plastic Surgery Procedures; Prosthesis-Related Infections; Reoperation; Staphylococcal Infections; Staphylococcus; Streptococcal Infections; Streptococcus anginosus; Sulbactam | 2021 |
Vertebral osteomyelitis caused by vancomycin-resistant Enterococcus spp.: a case series.
Topics: Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Daptomycin; Discitis; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Enterococcus faecium; Female; Gentamicins; Humans; Italy; Linezolid; Male; Middle Aged; Osteomyelitis; Retrospective Studies; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci; Young Adult | 2021 |
In vitro activities of thiazolidione derivatives combined with daptomycin against clinical Enterococcus faecium strains.
Topics: Ampicillin; Anti-Bacterial Agents; Biofilms; Daptomycin; Drug Synergism; Enterococcus faecium; Gram-Positive Bacterial Infections; Histidine Kinase; Humans; Microbial Sensitivity Tests; Recombinant Proteins; Thiazoles | 2022 |